WILLIAM BLAIR INVESTMENT MANAGEMENT, LLCWILLIAM BLAIR INVESTMENT MANAGEMENT, LLC

Institutional investor · Portfolio as of Q2 2020

SEC EDGAR SourceSEC Filings

Top Holdings341 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
TSMTSM
ADR

TAIWAN SEMICONDUCTOR SPONSORED ADR /1 ADR REPS 5 ORD SHS/

15M$850.2M3.5%$32.36+58.76%
7 qtrssince 2018-Q4
Decreased
0
SPYSPY
Unit

STATE STREET SPDR S&P 500 ETF TRUST CL USD INC

2M$602.4M2.5%$231.03+22.01%
7 qtrssince 2018-Q4
Decreased
0
NTESNTES
ADR

NETEASE INC-ADR

1.1M$466.4M1.9%$45.15+73.32%
7 qtrssince 2018-Q4
Decreased
0

BWX TECHNOLOGIES INC

7.6M$430.6M1.8%$37.51+40.72%
7 qtrssince 2018-Q4
Decreased
0

AMAZON.COM INC

154,063$425M1.7%$84.93+57.80%
7 qtrssince 2018-Q4
Increased
58

HORIZON THERAPEUTICS PLC

7.6M$423.5M1.7%
5 qtrssince 2019-Q2
Decreased
0

GRAND CANYON ED INC

4.1M$371.5M1.5%$92.66-2.31%
7 qtrssince 2018-Q4
Increased
49

MERCADOLIBRE INC

349,196$344.2M1.4%$746.99+31.30%
5 qtrssince 2019-Q2
Increased
76
TALTAL
ADR

TAL ED GROUP

4.8M$327.7M1.3%$46.99+43.51%
7 qtrssince 2018-Q4
Decreased
0

MICROSOFT CORP

1.5M$304.2M1.2%$117.72+60.94%
7 qtrssince 2018-Q4
Increased
59

CANADIAN NATL RAILWAY CO

3.4M$302.6M1.2%$66.44+18.00%
7 qtrssince 2018-Q4
Increased
53

ENCOMPASS HEALTH CORP

4.6M$282.6M1.2%$45.25-0.14%
7 qtrssince 2018-Q4
Increased
48
NICENICE
ADR

NICE LTD - SPON ADR

1.5M$281.7M1.1%$119.10+55.85%
7 qtrssince 2018-Q4
Increased
50

PURE STORAGE INC - CLASS A

16.2M$281.2M1.1%$16.89+1.81%
7 qtrssince 2018-Q4
Increased
49

ALPHABET INC-CL A

195,358$277M1.1%$55.36+25.24%
7 qtrssince 2018-Q4
Increased
56

LULULEMON ATHLETICA INC

882,672$275.4M1.1%$183.39+60.50%
7 qtrssince 2018-Q4
Increased
50

BJ'S WHOLESALE CLUB HOLDINGS

7.1M$266.3M1.1%$25.86+46.47%
5 qtrssince 2019-Q2
Decreased
0

TREX INC

2M$263.5M1.1%$31.56+102.84%
7 qtrssince 2018-Q4
Decreased
0

MARTIN MARIETTA MATERIALS

1.2M$246.6M1.0%$166.53+19.60%
7 qtrssince 2018-Q4
Increased
51
ZNGAZNGADelisted

ZYNGA INC

25.8M$245.9M1.0%
5 qtrssince 2019-Q2
Increased
49
$24.6B
AUM
341
Positions
Q2 2020
Filing
Rating · 2.5
Quarterly Portfolio Change
+18%Q1'19$23.8B+0%Q2'19$23.8B-2%Q3'19$23.4B+7%Q4'19$25.1B-18%Q1'20$20.5B+20%Q2'20$24.6B
Activity profile
$ moved · Q2'20
New12%Increased45%Decreased36%Exited7%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.2 years
<1Q7%1-4Q17%1-2Y77%2Y+0%

WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC manages $24.6B across 341 positions as of Q2 2020. Top holdings: TSM (3.5%), SPY (2.5%), NTES (1.9%). Fund DNA: Steady Compounder. HoldingsIntel Rating: 2.5/5.0.

Q2 2020 Summary

Active quarter - 32 new positions, 30 exits, 137 increased. Top move: MELI (INCREASED, conviction 76). Portfolio: $24.6B across 341 positions.

Top holdings by portfolio weight

Total AUM$25B
TSM3.46%
SPY2.45%
NTES1.90%
BWXT1.75%
AMZN1.73%
HZNP1.72%
LOPE1.51%
MELI1.40%
TAL1.33%
MSFT1.24%
Other1.23%

Portfolio allocation by GICS sector

Sectors11
Technology20.40%
Unknown15.66%
Healthcare14.36%
Consumer Cyclical12.79%
Industrials11.81%
Communication Services7.39%
Consumer Defensive6.57%
Financial Services6.28%
Real Estate2.08%
Basic Materials1.58%
Other1.08%

Behavioral investing profile

Checking access…
Steady Compounder- primarily Technology, Unknown, Healthcare
Compare DNA across all funds
7-dimension quality assessment
Solid(2.5 / 5.0)
Track Record69
Conviction41
Concentration43
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
DFINDFINDONNELLEY FINL SOLUTIONS INC
Q3 2024 Q2 2026+312,895 shares+$7.5M
7Q
PWPPWPPERELLA WEINBERG PARTNERS
Q4 2024 Q2 2026+3.2M shares+$46.8M
7Q
PRCTPRCTPROCEPT BIOROBOTICS CORP
Q4 2024 Q2 2026+496,982 shares-$1M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used